SCHEMBL5053643

SCHEMBL5053643

CCO[Si](OCC)(OCC)C(CC)NC(=O)c1ccccc1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 9/20 0.55
▸ ALDH1A1 P00352 6/20 0.55
▸ LMNA P02545 5/20 0.55
▸ HPGD P15428 5/20 0.55
▸ HSD17B10 Q99714 4/20 0.55
▸ TSHR P16473 2/20 0.55
▸ GAA P10253 6/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ RECQL P46063 1/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ TP53 P04637 3/20 0.46
▸ HTT P42858 3/20 0.46
▸ NAAA Q02083 1/20 0.43
▸ MPO P05164 1/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6105988 0.73 LMNA (0.69) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL28423022 0.73 HSD17B10 (0.48) KDM4EALDH1A1LMNAHSD17B10TSHR
SCHEMBL5803352 0.72 KDM4E (0.66) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL4561830 0.71 ALDH1A1 (0.32) ALDH1A1GAA
SCHEMBL810960 0.71 MEN1 (0.51) LMNAHSD17B10GAAKMT2AMEN1
SCHEMBL28426670 0.70 TAS1R3 (0.40) ALDH1A1HPGDKMT2AMEN1RAB9A
SCHEMBL14890370 0.70 ALDH1A1 (0.44) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL7154902 0.70 KDM4E (0.31) KDM4EALDH1A1LMNAHSD17B10SMN1; SMN2
SCHEMBL2145053 0.70 MGAM (0.33) ALDH1A1LMNAHSD17B10GAA
SCHEMBL5052168 0.69 NAAA (0.63) KDM4EALDH1A1HPGDHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080063720-A1 Cadmium telluride, cadmium selenide nanoparticles; water, lipid soluble; conjugated to drugs and theraputics to target tissues, membranes, cells, tumors, parasites, pathogens; diagnostics PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN, THE (IE) 2008-03-13 — — US disclosed
WO-2005105035-A2 TARGETED NANOPARTICLES FOR DRUG DELIVERY THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH (IE) 2005-11-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080063720-A1 Cadmium telluride, cadmium selenide nanoparticles; water, lipid soluble; conjugated to drugs and theraputics to target tissues, membranes, cells, tumors, parasites, pathogens; diagnostics CD2BP2, TBCD, SLC30A6 KDM4E 4462/4885ALDH1A1 3156/4885LMNA 2963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback